People / Staff

Arielle Kane

Arielle Kane is the director of health care at PPI. Her research focuses on what comes next for health policy in order to expand access, reduce costs and improve quality. Specifically, she focusses on how innovation in health care can help meet the goals of the triple aim. Prior to joining PPI, she worked at the Deloitte Center for Health Solutions where she researched provider issues, including conducting a survey of health system CEOs on the future of health care; policy issues, including analysis of the recent tax overhaul; and managed a weekly newsletter which provided updates and analysis on health policy and industry news. Arielle also worked in Oregon politics prior to moving to Washington, DC. Arielle received her Master of Public Policy from Georgetown University. She lives in Washington, DC with her bulldog, Hank.

Writings

Other

By / 1.25.2019

Despite a strong economy and low unemployment, the number of Americans who lack health insurance is rising. The uninsured rate among adults in the fourth quarter of 2018 climbed to 13.7 percent, well above the low point of 10.9 percent in 2016, according to Gallup’s National Health and Well-Being Index. That means 7 million Americans […]

Op-eds and Articles

By / 12.19.2018

Republicans love to complain about “activist judges,” that is, until they find one willing to do their political bidding. On Friday, members of the GOP hailed a ruling by U.S. District Judge Reed O’Connor striking down the Affordable Care Act (ACA) as unconstitutional. They didn’t seem to care that O’Connor had to use some highly […]

Blog

By / 11.19.2018

Health care costs continue to be top of mind for a plurality of voters, according to a recent poll by PPI and Expedition Strategies. Our poll surveyed 1,090 likely voters on to gather data to apply context and to for what kind of agenda progressives should craft as the 2020 election cycle dawns. Health care […]

Publications

By / 10.24.2018

“Millions of our citizens do not now have a full measure of opportunity to achieve and enjoy good health. Millions do not now have protection or security against the economic effects of sickness. The time has arrived for action to help them attain that opportunity and that protection.” –President Harry Truman, 1945

Publications

By / 10.3.2018

Carl Icahn, the billionaire businessman and investor, recently advised shareholders to reject Cigna’s proposed $67 billion acquisition of the pharmacy benefit manager (PBM) Express Scripts. He says that a reckoning is coming for PBMs and that the price grossly exaggerated their value as “over-earning middle men.” In 2016, PBMs made $23 billion in gross profits […]

Blog

By / 8.28.2018

The drug industry, like any industry, has its share of bad actors. The loathsome Martin Shkreli is now serving time after his company, Turing Pharmaceuticals, jacked up the cost of a lifesaving AIDS drug by 5,000 percent. Mylan, a Dutch company, was caught overcharging the federal Medicaid program $1.27 billion for EpiPens, used to protect […]

Op-eds and Articles

By / 8.8.2018

Last week, the Centers for Medicare and Medicaid Services (CMS) announced that it had approved a reinsurance proposal in Wisconsin and Maine in an effort to keep health premiums down. Reinsurance is essentially insurance for insurers: The government helps pay for the cost of exceptionally high-cost claims. It’s no wonder states have been working on […]

Blog

By / 8.3.2018

President Trump promised Americans cheaper and better health care than what is provided under the Affordable Care Act (ACA). Yet his latest move, to expand access to short-term, limited-duration health plans, may make insurance cheaper but far from better. These short-term plans have existed under the ACA as a short-term stop-gap measure for people in […]

Publications

By / 7.19.2018

Americans who buy health insurance on the exchanges set up by the Affordable Care Act (ACA) are having sticker shock as preliminary rates are filed for the 2019 plan year. Healthcare analysts expect insurance premiums to skyrocket during the next open enrollment period, which inconveniently begins just before the 2018 midterm elections. These higher premiums […]

Op-eds and Articles

By / 7.11.2018

President Trump’s nomination of Judge Brett Kavanaugh to fill the seat on the Supreme Court vacated by Justice Anthony Kennedy have left many to wonder: What will replacing an often swing vote with a more conservative one mean for health care? There are many pending cases in lower courts that, if they make it a […]